By ‘monetising’ I meant something like a licensing deal with an upfront cash injection of, say, $50m -$100m, to sustain IMU’s oncolytic virus trials. Precision Bioscience still gets their cut. Azer-cel is IMU’s most advanced asset, so I wonder if something is brewing… or coming to the boil.
Just my musings, I have no idea. ♂️
IMU Price at posting:
2.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)